OpGen is a precision medicine company that develops and commercializes molecular microbiology solutions globally, utilizing artificial intelligence and next-generation sequencing technology to combat infectious diseases. Its product portfolio includes the Acuitas AMR Gene Panel for detecting bacterial nucleic acids and genetic determinants of antimicrobial resistance, the Curetis CE-IVD-marked PCR-based SARS-CoV-2 test kits, and the Unyvero Platform, an automated sample-to-answer molecular diagnostics platform. OpGen's solutions provide information to clinicians to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms.